Jatenzo Capsule, Liquid Filled
Product Images NDC 69087-237

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Jatenzo (NDC 69087-237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tolmar Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (Clarus 158mg)

Bottle Label (Clarus 158mg)
Jatenzo 158 mg testosterone undecanoate capsules label showing the oral liquid-filled gelatin capsules in a bottle package. The label includes storage instructions, active ingredient, NDC 69087-158-12, 120 capsules count, RX only, and is manufactured by TOLMAR Inc. The label also displays a barcode and regulatory symbols.*
FDA Label Image

Bottle Label (Clarus 198mg)

Bottle Label (Clarus 198mg)
Jatenzo 198 mg capsules label showing testosterone undecanoate as the active ingredient. The label indicates storage instructions, package size of 120 soft gelatin capsules, and is marked for RX only. Labeler is Clarus Therapeutics. The label includes the NDC 69087-198-12 and warnings about child safety and excipients.*
FDA Label Image

Bottle Label (Clarus 237mg)

Bottle Label (Clarus 237mg)
Jatenzo 237 mg capsules label displaying the active ingredient testosterone undecanoate. The label indicates 120 soft gelatin capsules in the package, for oral use, by prescription only. It includes storage instructions, the NDC number 69087-237-12, and the labeler Clarus Therapeutics.*
FDA Label Image

Figure 1 (Jat01 0002 01)

Figure 1 (Jat01 0002 01)
Chemical structure of testosterone undecanoate, showing the steroid backbone with attached undecanoate side chain esterified at the 17-beta hydroxyl group.*
FDA Label Image

Figure 2 (Jat01 0002 02)

Figure 2 (Jat01 0002 02)
A line graph depicting plasma testosterone concentration (ng/dL) over 24 hours following a morning dose of Jatenzo. The x-axis shows time in hours post-dose, and the y-axis shows plasma testosterone concentration with markers for Normal Range and Final Visit values. The graph illustrates plasma concentration changes throughout the day.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.